Milk fat globule membrane-enriched milk improves episodic memory: A randomized, parallel, double-blind, placebo-controlled trial in older adults

被引:14
作者
Calvo, Maria V. [1 ]
Kohen, Viviana Loria [2 ,3 ]
Diaz-Mardomingo, Carmen [4 ]
Garcia-Herranz, Sara [4 ]
Baliyan, Shishir [4 ]
Tome-Carneiro, Joao [2 ]
Colmenarejo, Gonzalo [2 ]
Visioli, Francesco [5 ]
Venero, Cesar [4 ,6 ]
Fontecha, Javier [1 ,6 ]
机构
[1] UAM, CSIC, Inst Food Sci Res CIAL, Food Lipid Biomarkers & Hlth Grp, Madrid, Spain
[2] CEI UAM, IMDEA Food, Madrid, Spain
[3] Univ Complutense Madrid, Fac Pharm, Dept Nutr & Food Sci, VALORNUT Res Grp, Madrid, Spain
[4] UNED, Fac Psychol, Cogni UNED Res Grp, Madrid, Spain
[5] Univ Padua, Dept Mol Med, Padua, Italy
[6] UAM, CSIC, Inst Food Sci Res CIAL, C Nicolas Cabrera 9, Madrid 28049, Spain
关键词
milk fat globule membrane (MFGM); Cognitive decline; Memory; Aging; Phospholipids; Randomized controlled trial; COGNITIVE PERFORMANCE; PHOSPHATIDYLSERINE; IMPAIRMENT; INTERVENTION; PREDICTORS; METABOLISM; COMPLAINTS; DISEASE; STRESS;
D O I
10.1016/j.jff.2023.105849
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Cognitive decline is one of the most important consequences of aging and pharmacological therapies had been largely unsuccessful. Other strategies include the use of functional foods to reduce the burden of cognitive decline. The MFGM is an important source of polar lipids and glycoproteins that decline in the aging brain. We have developed a milk drink fortified with MFGM (MFGM-M) as a dietary supplement and studied it in a randomized clinical pilot study. Forty-four > 65-year-old healthy or mildly cognitively impaired subjects received MFGM-M or control milk (CM) for 14 weeks, during which they underwent a battery of cognitive tests. Lipidomic analyzes were also performed. The female participants showed improvement in episodic memory, the ability to recall events in our lives. It is conceivable that any intervention should be started before clinical symptoms manifest, as a preventive measure against cognitive decline. Future long-term studies may shed further light on this point.
引用
收藏
页数:11
相关论文
共 82 条
[41]   Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective [J].
Kumaran, Kesevan Rajah ;
Yunusa, Suleiman ;
Perimal, Enoch ;
Wahab, Habibah ;
Mueller, Christian P. ;
Hassan, Zurina .
JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (02) :507-530
[42]   An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease [J].
Langbaum, Jessica B. ;
Hendrix, Suzanne B. ;
Ayutyanont, Napatkamon ;
Chen, Kewei ;
Fleisher, Adam S. ;
Shah, Raj C. ;
Barnes, Lisa L. ;
Bennett, David A. ;
Tariot, Pierre N. ;
Reiman, Eric M. .
ALZHEIMERS & DEMENTIA, 2014, 10 (06) :666-674
[43]   Overwriting of phonemic features in serial recall [J].
Lange, EB ;
Oberauer, K .
MEMORY, 2005, 13 (3-4) :333-339
[44]   Oral administration of squid lecithin-transphosphatidylated phosphatidylserine improves memory impairment in aged rats [J].
Lee, Bombi ;
Sur, Bong-Jun ;
Han, Jeong-Jun ;
Shim, Insop ;
Her, Song ;
Lee, Yang-Seok ;
Lee, Hye-Jung ;
Hahm, Dae-Hyun .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 56 :1-10
[45]   In vivo HMRS and lipidomic profiling reveals comprehensive changes of hippocampal metabolism during aging in mice [J].
Lin, Lejun ;
Cao, Bofeng ;
Xu, Zhiying ;
Sui, Yanbin ;
Chen, Jiao ;
Luan, Qiang ;
Yang, Ruifang ;
Li, Shanchun ;
Li, Ke Feng .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (01) :9-14
[46]  
lobo A., 1979, Actas Luso-Espanolas de Neurologia y Psiquiatria, V7, P189
[47]   Alzheimer Disease: An Update on Pathobiology and Treatment Strategies [J].
Long, Justin M. ;
Holtzman, David M. .
CELL, 2019, 179 (02) :312-339
[48]  
Loughman Amy, 2021, Mod Trends Psychiatry, V32, P100, DOI 10.1159/000510422
[49]   Nutritional psychiatry: the present state of the evidence [J].
Marx, Wolfgang ;
Moseley, Genevieve ;
Berk, Michael ;
Jacka, Felice .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2017, 76 (04) :427-436
[50]   Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients [J].
Massot Mesquida, Mireia ;
Folkvord, Frans ;
Seda, Gemma ;
Lupianez-Villanueva, Francisco ;
Toran Monserrat, Pere .
BMC GERIATRICS, 2021, 21 (01)